Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:995 (11 November), doi:10.1136/bmj.38977.590752.0B (published 20 October 2006)
Elaine M Hay, professor/consultant in community rheumatology1, Nadine E Foster, DoH primary care career scientist and senior lecturer in therapies1, Elaine Thomas, senior lecturer in biostatistics1, George Peat, senior lecturer in clinical epidemiology1, Mike Phelan, medication review pharmacist1, Hannah E Yates, research nurse1, Alison Blenkinsopp, professor of the practice of pharmacy2, Julius Sim, professor of health care research1
1 Primary Care Musculoskeletal Research Centre, Keele University, Keele, 2 Medicines Management, Keele University
Correspondence to: E M Hay e.m.hay{at}cphc.keele.ac.uk
Design Pragmatic multicentre randomised clinical trial.
Setting 15 general practices in North Staffordshire.
Participants 325 adults aged 55 years or over (mean 68 years) consulting with knee pain; 297 (91%) reached six month follow-up.
Interventions Enhanced pharmacy review (pharmacological management in accordance with an algorithm); community physiotherapy (advice about activity and pacing and an individualised exercise programme); control (advice leaflet reinforced by telephone call).
Main outcome measure Change in Western Ontario and McMaster Universities osteoarthritis index (WOMAC) at 3, 6, and 12 months.
Results Mean baseline WOMAC pain score was 9.1 (SD 3.7), and mean baseline function score was 29.9 (SD 12.8). At three months, the mean reductions in pain scores were 0.41 (SD 2.8) for control, 1.59 (3.2) for pharmacy, and 1.56 (3.4) for physiotherapy; reductions in function scores were 0.80 (8.5), 2.61 (9.8), and 4.79 (10.8). Compared with control, mean differences in change scores for physiotherapy were 1.15 (95% confidence interval 0.2 to 2.1) for pain and 3.99 (1.2 to 6.8) for function; those for pharmacy were 1.18 (0.3 to 2.1) for pain and 1.80 (0.8 to 4.5) for function. These differences were not sustained to six or 12 months. Significantly fewer participants in the physiotherapy group reported consulting their general practitioner for knee pain in the follow-up period, and use of non-steroidal anti-inflammatory drugs was lower in the physiotherapy and pharmacy groups than in the control group.
Conclusions Evidence based care for older adults with knee pain, delivered by primary care physiotherapists and pharmacists, resulted in short term improvements in health outcomes, reduced use of non-steroidal anti-inflammatory drugs, and high patient satisfaction. Physiotherapy seemed to produce a shift in consultation behaviour away from the traditional general practitioner led model of care.
Trial registration UK National Research Register N0286046917; Current Controlled Trials ISRCTN55376150 [controlled-trials.com] .
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses